Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biogen Inc (NASDAQ:BIIB)

280.32
Delayed Data
As of Jun 23
 -0.25 / -0.09%
Today’s Change
205.42
Today|||52-Week Range
307.33
+7.32%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Operating ActivitiesNet Income / Starting Line1.0B1.0B647.9M747.5M
 
 
 
 
 
Depreciation175.4M180.2M177.4M512.0M
 
 
 
 
 
Total Other Cash Flow78.8M47.3M94.8M55.1M
 
 
 
 
 
Funds From Operations1.3B1.2B801.9M1.4B
 
 
 
 
 
Funds From/For Other Operating Expenses267.7M244.5M-774.7M1.2B
 
 
 
 
 
Net Cash Flow - Operating Activities995.8M986.6M1.6B235.2M
 
 
 
 
 
 
InvestingIncrease In Investments-1.9B-1.8B-2.3B-1.3B
 
 
 
 
 
Decrease In Investments1.6B2.4B2.2B1.9B
 
 
 
 
 
Capital Expenditures-136.8M-170.3M-182.1M-210.0M
 
 
 
 
 
Other Investing - Uses-322.9M-246.9M-310.0M-306.6M
 
 
 
 
 
Net Cash Flow Investing-736.1M36.2M-581.7M-744.2M
 
 
 
 
 
 
FinancingShort Term Borrowings----------
Long Term Borrowings----0.00----
Long Term Debt Reduction----0.00----
Net Proceeds Stock Sale9.4M11.3M8.5M0.00
 
 
 
 
Common Preferred Redeemed0.00-348.9M-651.1M-583.6M
 
 
 
 
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing-22.8M39.7M-37.2M10.4M
 
 
 
 
 
Other Uses - Financing------328.2M
 
 
Net Cash Flow - Financing-13.4M-300.6M-721.2M-901.4M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-15.0M600.0K-32.0M7.9M
 
 
 
 
 
 
Net Change In Cash246.3M722.2M273.7M-1.4B